u/Pristine-Step-6009

Cupid (yes, the condom/FemCare manufacturer) has been one of India's wildest small-cap runs, and the numbers are genuinely eye-popping.

The bull case: FY26 revenue jumped 113% year-over-year to ₹3.91 billion, with net income up 165% and profit margins expanding to 28%. Q3 FY26 was even stronger — EPS more than tripled and profit margins hit 32%. The company's diversifying beyond condoms into deodorants, perfumes, IVD test kits, and other FMCG personal care products, and a promoter recently bought 21 lakh shares in the open market — insider buying is usually a good signal.

The bear case: This growth is already priced in, aggressively. The stock trades at a P/E of 247, and over the last 3 years, EPS grew 42% annually while the share price grew 260% annually — that's a huge disconnect between fundamentals and price. It's also more volatile than 75% of Indian stocks, moving about 8.6% a week. A recent 4:1 bonus issue also inflated the share count, so compare metrics carefully.

Real earnings momentum, but valuation leaves zero room for a stumble. This is a "size your position like it could gap down 20% on any miss" stock, not a core holding.